EP2293076 - Bibliographic data

Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease

Last update 05/07/2025
Legal status Brevet déchu
Origin Européen

(73) Holder

B.R.A.H.M.S GMBH

Neuendorfstrasse 25
16761 Hennigsdorf
Allemagne
(72) Inventors

Struck, Joachim

B.R.A.H.M.S GmbH Zerndorfer Weg 52a
13465 Berlin
Allemagne

Bergmann, Andreas

B.R.A.H.M.S GmbH Baumläuferweg 47
12351 Berlin
Allemagne
(74) Agent

Mail recipient

Hertin und Partner Rechts- und Patentanwälte PartG mbB

Kurfürstendamm 54/55
10707 Berlin
Allemagne

(21) Request number EP10188289.2
(22) Request date 01/08/2008

(11) Publication number EP2293076
Publication date 19/12/2012

(54) Title of the invention Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
(51) International classification G01N 33/68G01N 33/74
International classification (before reform) None

Claimed priority

(31) Number: 07015271
(32) Date: 03/08/2007
(33) Country: EP


(31) Number: 08152651
(32) Date: 12/03/2008
(33) Country: EP

Initial application None
Divisional application None

Expected annuity Annuity: 6 - Amount: 75 € - Due date 02/09/2013
Surtax: 6 - Amount: 15 € - Due date 03/03/2014
Last annuity None

Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2012/4, of 31/12/2012

History

Publication de la délivrance du brevet européen - Legal date 19/12/2012


Entrée en période de grâce du brevet d'invention - Legal date 02/09/2013


Déchéance du brevet d'invention après période de grâce - Legal date 02/09/2013


Modification du mandataire OEB du brevet européen - Legal date 13/01/2017


Modification du mandataire OEB du brevet européen - Legal date 10/01/2020